Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma
Open accessAbstract
Giant congenital naevi are pigmented childhood lesions that frequently lead to melanoma, the most aggressive skin cancer. The mechanisms underlying this malignancy are largely unknown, and there are no effective therapies. Here we describe a mouse model for giant congenital naevi and show that naevi and melanoma prominently express Sox10, a transcription factor crucial for the formation of melanocytes from the neural crest. Strikingly, Sox10 haploinsufficiency counteracts Nras(Q61K)-driven congenital naevus and melanoma formation without affecting the physiological functions of neural crest derivatives in the skin. Moreover, Sox10 is also crucial for the maintenance of neoplastic cells in vivo. In human patients, virtually all congenital naevi and melanomas are SOX10 positive. Furthermore, SOX10 silencing in human melanoma cells suppresses neural crest stem cell properties, counteracts proliferation and cell survival, and completely abolishes in vivo tumour formation. Thus, SOX10 represents a promising target for the treatment of congenital naevi and melanoma in human patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some NCSC factors, such as SOX10 and YY1, are activated upon melanoma formation and are required for melanoma growth.
“while some NCSC factors, such as SOX10 and YY1, are activated upon melanoma formation and are required for melanoma growth16,19,29,69”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works
The transcription factor Sox10 is a key regulator of peripheral glial developmentPreprint
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M. J., Nave, K., Birchmeier, C., & Wegner, M. (2001) · Genes & Development · doi:10.1101/gad.186601 · Cited by 915 · see citing works
Self-citationDominant role of the niche in melanocyte stem-cell fate determination
Nishimura, E. K., Jordan, S. A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I. J., Barrandon, Y., Miyachi, Y., & Nishikawa, S. (2002) · Nature · doi:10.1038/416854a · Cited by 900 · see citing works
Self-citationSOX10 mutations in patients with Waardenburg-Hirschsprung disease
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Préhu, M., Puliti, A., Herbarth, B., Hermans‐Borgmeyer, I., Legius, E., Matthijs, G., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-171 · Cited by 820 · see citing works
Self-citationHuman melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., Butler, P. D., Yang, G. P., Joshua, B., Kaplan, M. J., et al. (2010) · Nature · doi:10.1038/nature09161 · Cited by 714 · see citing works
SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells.
Kim, J., Lo, L., Dormand, E., & Anderson, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00163-6 · Cited by 584 · see citing works
Hoek, K. S., Schlegel, N. C., Brafford, P. A., Sucker, A., Ugurel, S., Kumar, R., Weber, B. L., Nathanson, K. L., Phillips, D. J., Herlyn, M., et al. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00322.x · Cited by 543 · see citing works
Self-citationSox10: A Pan-Schwannian and Melanocytic Marker
Nonaka, D., Chiriboga, L. A., & Rubin, B. P. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181658c14 · Cited by 407 · see citing works
Pax3 functions at a nodal point in melanocyte stem cell differentiation
Lang, D., Lu, M. M., Huang, L., Engleka, K. A., Zhang, M., Chu, E. Y., Lipner, S., Skoultchi, A., Millar, S. E., & Epstein, J. A. (2005) · Nature · doi:10.1038/nature03292 · Cited by 397 · see citing works
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans‐Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M., & Wegner, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5161 · Cited by 369 · see citing works
Self-citationCongenital Melanocytic Nevi Frequently Harbor NRAS Mutations but no BRAF Mutations
Bauer, J. M., Curtin, J. A., Pinkel, D., & Bastian, B. C. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700490 · Cited by 350 · see citing works
Paratore, C., Goerich, D. E., Suter, U., Wegner, M., & Sommer, L. (2001) · Development · doi:10.1242/dev.128.20.3949 · Cited by 337 · see citing works
Self-citationCivenni, G., Walter, A., Kobert, N., Mihic‐Probst, D., Zipser, M. C., Belloni, B., Seifert, B., Moch, H., Dummer, R., van den Broek, M. F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3997 · Cited by 325 · see citing works
Self-citationRabbani, P. S., Takeo, M., Chou, W. C., Myung, P. S., Bosenberg, M., Chin, L., Taketo, M. M., & Ito, M. (2011) · Cell · doi:10.1016/j.cell.2011.05.004 · Cited by 321 · see citing works
Wong, C. E., Paratore, C., Dours-Zimmermann, M. T., Rochat, A., Pietri, T., Suter, U., Zimmermann, D. R., Dufour, S., Thiery, J. P., Meijer, D., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606062 · Cited by 315 · see citing works
Self-citationAckermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., & Beermann, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2970 · Cited by 308 · see citing works
Self-citationSox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage
Finzsch, M., Schreiner, S., Kichko, T. I., Reeh, P. W., Tamm, E. R., Bösl, M. R., Meijer, D., & Wegner, M. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912142 · Cited by 243 · see citing works
Self-citationMaintenance of mammalian enteric nervous system progenitors by SOX10 and endothelin 3 signalling
Bondurand, N., Natarajan, D., Barlow, A. J., Thapar, N., & Pachnis, V. (2006) · Development · doi:10.1242/dev.02375 · Cited by 171 · see citing works
Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice
Bosenberg, M., Muthusamy, V., Curley, D. P., Wang, Z., Hobbs, C., Nelson, B., Nogueira, C., Horner, J. W., DePinho, R. A., & Chin, L. (2006) · genesis · doi:10.1002/dvg.20205 · Cited by 160 · see citing works
Generation of melanocytes from neural crest cells
Sommer, L. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00834.x · Cited by 156 · see citing works
Self-citationThe Sox10Dom Mouse: Modeling the Genetic Variation of Waardenburg-Shah (WS4) SyndromePreprint
Southard‐Smith, E. M., Angrist, M. H., Ellison, J., Agarwala, R., Baxevanis, A. D., Chakravarti, A., & Pavan, W. J. (1999) · Genome Research · doi:10.1101/gr.9.3.215 · Cited by 156 · see citing works
Paratore, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3075 · Cited by 153 · see citing works
Functional Analysis of Sox10 Mutations Found in Human Waardenburg-Hirschsprung Patients
Kuhlbrodt, K., Schmidt, C. S., Sock, E., Pingault, V., Bondurand, N., Goossens, M., & Wegner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23033 · Cited by 139 · see citing works
Self-citationNAKATO, N., Takata, M., Takayanagi, S., Takashima, S., Lin, J., Murata, H., Fujimoto, A., Hatta, N., & Saida, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700366 · Cited by 136 · see citing works
Consistent expression of the stem cell renewal factor BMI‐1 in primary and metastatic melanoma
Mihic‐Probst, D., Kuster, A., Kilgus, S., Bode‐Lesniewska, B., Ingold‐Heppner, B., Leung, C., Storz, M., Seifert, B., Marino, S., Schraml, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22891 · Cited by 106 · see citing works
Self-citationBondurand, N., Kuhlbrodt, K., Pingault, V., Enderich, J., Sajus, M., Tommerup, N., Warburg, M., Hennekam, R. C. M., Read, A., Wegner, M., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1785 · Cited by 106 · see citing works
Self-citationThe transcription factor Sox5 modulates Sox10 function during melanocyte development
Stolt, C. C., Lommes, P., Hillgärtner, S., & Wegner, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn527 · Cited by 93 · see citing works
Self-citationJohn, N., Cinelli, P., Wegner, M., & Sommer, L. (2011) · Stem Cells · doi:10.1002/stem.607 · Cited by 67 · see citing works
Self-citationNestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma
Bakos, R. M., Maier, T., Besch, R., Mestel, D. S., Ruzicka, T., Sturm, R. A., & Berking, C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00991.x · Cited by 66 · see citing works
The discovery of the microphthalmia locus and its gene, Mitf
Arnheiter, H. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00759.x · Cited by 58 · see citing works
Genetics and genomics of melanoma
Ghosh, P., & Chin, L. (2009) · Expert Review of Dermatology · doi:10.1586/edm.09.2 · Cited by 57 · see citing works
SOX9 and SOX10 but Not BRN2 Are Required for Nestin Expression in Human Melanoma Cells
Flammiger, A., Besch, R., Cook, A. L., Maier, T., Sturm, R. A., & Berking, C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.316 · Cited by 51 · see citing works
SOX10 expression in superficial spreading and nodular malignant melanomas
Agnarsdóttir, M., Sooman, L., Bolander, Å., Strömberg, S., Rexhepaj, E., Bergqvist, M., Pontén, F., Gallagher, W. M., Lennartsson, J., Ekman, S., et al. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e3283403ccd · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tsoi, J., Robert, L., Paraiso, K., Galvan, C., Sheu, K. M., Lay, J., Wong, D. J. L., Atefi, M., Shirazi, R., Wang, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.017 · Cited by 938 · see citing works
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Verfaillie, A., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7683 · Cited by 489 · see citing works
The role of SOX family members in solid tumours and metastasis
Grimm, D. G., Bauer, J. W., Wise, P. M., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487 · see citing works
Goding, C. R., & Arnheiter, H. (2019) · Genes & Development · doi:10.1101/gad.324657.119 · Cited by 430 · see citing works
The melanocyte lineage in development and disease
Mort, R. L., Jackson, I. J., & Patton, E. E. (2015) · Development · doi:10.1242/dev.106567 · Cited by 416 · see citing works
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation
Kaufman, C. K., Mosimann, C., Fan, Z. P., Yang, S. P., Thomas, A. J., Ablain, J., Tan, J. L., Fogley, R. D., van Rooijen, E., Hagedorn, E. J., et al. (2016) · Science · doi:10.1126/science.aad2197 · Cited by 387 · see citing works
Signal pathways of melanoma and targeted therapy
Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 403 · see citing works
Zingg, D., Debbache, J., Schaefer, S. M., Tuncer, E., Frommel, S. C., Cheng, P. F., Arenas-Ramirez, N., Häusel, J., Zhang, Y., Bonalli, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7051 · Cited by 331 · see citing works
Self-citationThe Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Zingg, D., Arenas-Ramirez, N., Şahin, D., Rosalia, R. A., Antunes, A. T., Häusel, J., Sommer, L., & Boyman, O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.007 · Cited by 329 · see citing works
Self-citationWellbrock, C., & Arozarena, I. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12370 · Cited by 218 · see citing works
Pathways and therapeutic targets in melanoma
Shtivelman, E., Davies, M. A., Hwu, P., Yang, J. C.-H., Lotem, M., Oren, M., Flaherty, K. T., & Fisher, D. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1892 · Cited by 219 · see citing works
Neurocristopathies: New insights 150 years after the neural crest discovery
Vega‐López, G. A., Cerrizuela, S., Tríbulo, C., & Aybar, M. J. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.05.013 · Cited by 202 · see citing works
Melanoma models for the next generation of therapies
Patton, E. E., Mueller, K. L., Adams, D. J., Anandasabapathy, N., Aplin, A. E., Bertolotto, C., Bosenberg, M., Ceol, C. J., Burd, C. E., Chi, P., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.011 · Cited by 204 · see citing works
Injury-activated glial cells promote wound healing of the adult skin in mice
Parfejevs, V., Debbache, J., Shakhova, O., Schaefer, S. M., Glausch, M., Wegner, M., Suter, U., Riekstiņa, U., Werner, S., & Sommer, L. (2018) · Nature Communications · doi:10.1038/s41467-017-01488-2 · Cited by 202 · see citing works
Self-citationOhtomo, R., Mori, T., Shibata, S., Tsuta, K., Maeshima, A. M., Akazawa, C., Watabe, Y., Honda, K., Yamada, T., Yoshimoto, S., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.54 · Cited by 183 · see citing works
Roh, M. R., Eliades, P. J., Gupta, S., & Tsao, H. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12412 · Cited by 180 · see citing works
NRAS mutant melanoma: biological behavior and future strategies for therapeutic management
Fedorenko, I. V., Gibney, G. T., & Smalley, K. S. M. (2012) · Oncogene · doi:10.1038/onc.2012.453 · Cited by 171 · see citing works
Developmental chromatin programs determine oncogenic competence in melanoma
Baggiolini, A., Callahan, S. J., Montal, E. D., Weiss, J. M., Trieu, T., Tagore, M. M., Tischfield, S. E., Walsh, R. M., Suresh, S., Fan, Y., et al. (2021) · Science · doi:10.1126/science.abc1048 · Cited by 150 · see citing works
Insights into neural crest development and evolution from genomic analysisPreprint
Simões-Costa, M., & Bronner-Fraser, M. E. (2013) · Genome Research · doi:10.1101/gr.157586.113 · Cited by 127 · see citing works
The melanocyte lineage in development and disease
Mort, R. L., Jackson, I. J., & Patton, E. E. (2015) · Development · doi:10.1242/dev.123729 · Cited by 118 · see citing works
Seberg, H., Otterloo, E. V., & Cornell, R. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12611 · Cited by 113 · see citing works
Shakhova, O., Cheng, P., Mishra, P. J., Zingg, D., Schaefer, S. M., Debbache, J., Häusel, J., Matter, C., Guo, T., Davis, S., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004877 · Cited by 111 · see citing works
Self-citationAlonso‐Curbelo, D., Riveiro‐Falkenbach, E., Pérez‐Guijarro, E., Cifdaloz, M., Karras, P., Osterloh, L., Megı́as, D., Cañón, E., Calvo, T. G., Olmeda, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.030 · Cited by 110 · see citing works
Harris, M. L., Buac, K., Shakhova, O., Hakami, R. M., Wegner, M., Sommer, L., & Pavan, W. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003644 · Cited by 110 · see citing works
Self-citationThe Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis
Baron, M., Tagore, M. M., Hunter, M. V., Kim, I. S., Moncada, R. M., Yan, Y., Campbell, N. R., White, R. M., & Yanai, I. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.018 · Cited by 108 · see citing works
SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis
Cronin, J. C., Watkins‐Chow, D. E., Incao, A. A., Hasskamp, J. H., Schönewolf, N., Aoude, L. G., Hayward, N. K., Bastian, B. C., Dummer, R., Loftus, S. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4620 · Cited by 104 · see citing works
Self-citationDevelopmental pathways activated in melanocytes and melanoma
Liu, J., Fukunaga‐Kalabis, M., Li, L., & Herlyn, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.023 · Cited by 103 · see citing works
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Wu, Y., Fletcher, M., Gu, Z., Wang, Q., Costa, B., Bertoni, A., Man, K.-H., Schlotter, M., Felsberg, J., Mangei, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20225-w · Cited by 101 · see citing works
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Young, A., Ngiow, S. F., Madore, J., Reinhardt, J., Landsberg, J., Chitsazan, A., Rautela, J., Bald, T., Barkauskas, D. S., Ahern, E. S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0393 · Cited by 99 · see citing works
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Capparelli, C., Purwin, T. J., Glasheen, M. Q., Caksa, S., Tiago, M., Wilski, N. A., Pomante, D., Rosenbaum, S. R., Nguyen, M. Q., Cai, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28801-y · Cited by 100 · see citing works
Wouters, J., Vizoso, M., Martínez‐Cardús, A., Carmona, F. J., Govaere, O., Laguna, T., Joseph, J., Dynoodt, P., Aura, C. M., Foth, M., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0851-3 · Cited by 98 · see citing works
Redmer, T., Welte, Y., Behrens, D., Fichtner, I., Przybilla, D., Wruck, W., Yaspo, M., Lehrach, H. R., Schäfer, R., & Regenbrecht, C. R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092596 · Cited by 98 · see citing works
SOX10 Promotes Melanoma Cell Invasion by Regulating Melanoma Inhibitory Activity
Graf, S. A., Busch, C., Bosserhoff, A., Besch, R., & Berking, C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.128 · Cited by 90 · see citing works
Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas
Ivanov, S. V., Panaccione, A., Nonaka, D., Prasad, M. L., Boyd, K. L., Brown, B. T., Guo, Y. P., Sewell, A. B., & Yarbrough, W. G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.326 · Cited by 89 · see citing works
Huang, Y.-H., Jankowski, A., Cheah, K. S. E., Prabhakar, S., & Jauch, R. (2015) · Scientific Reports · doi:10.1038/srep10398 · Cited by 86 · see citing works
Xu, X., Zhang, D., Kong, P., Gao, Y., Huang, X.-F., Song, Y., Zhang, W., Guo, R., Li, C., Chen, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112869 · Cited by 86 · see citing works
Han, S., Ren, Y., He, W., Liu, H., Zhi, Z., Zhu, X., Yang, T., Rong, Y., Ma, B., Purwin, T. J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02354-x · Cited by 80 · see citing works
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer
Patel, S. A., Hirosue, S., Rodrigues, P., Vojtasova, E., Richardson, E. K., Ge, J., Syafruddin, S. E., Speed, A., Papachristou, E. K., Baker, D., et al. (2022) · Nature · doi:10.1038/s41586-022-04809-8 · Cited by 83 · see citing works
The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
Restivo, G., Diener, J., Cheng, P. F., Kiowski, G., Bonalli, M., Biedermann, T., Reichmann, E., Levesque, M. P., Dummer, R., & Sommer, L. (2017) · Nature Communications · doi:10.1038/s41467-017-01573-6 · Cited by 82 · see citing works
Self-citationKim, H., Frederick, D. T., Levesque, M. P., Cooper, Z. A., Feng, Y., Krepler, C., Brill, L. M., Samuels, Y., Hayward, N. K., Perlina, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.049 · Cited by 77 · see citing works
Self-citationA caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity
Conde‐Perez, A., Gros, G., Longvert, C., Pedersen, M., Petit, V., Aktary, Z., Virós, A., Gesbert, F., Delmas, V., Rambow, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms9093 · Cited by 76 · see citing works
Pedersen, M., Küsters‐Vandevelde, H. V. N., Virós, A., Groenen, P. J. T. A., Sánchez‐Laorden, B. L., Gilhuis, J. H., Grunsven, I. A. V. E.-V., Renier, W. O., Schieving, J., Niculescu‐Duvaz, I., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0464 · Cited by 75 · see citing works
Whole‐exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets
Lyu, J., Song, Z., Chen, J., Shepard, M. J., Song, H., Ren, G., Li, Z., Guo, W., Zhuang, Z., & Shi, Y. (2017) · The Journal of Pathology · doi:10.1002/path.5017 · Cited by 74 · see citing works
Ennen, M., Keime, C., Gambi, G., Kieny, A., Coassolo, S., Thibault-Carpentier, C., Margerin-Schaller, F., Davidson, G., Vagne, C., Lipsker, D. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0010 · Cited by 73 · see citing works
Tong, X., Li, L., Li, X., Lei, H., Zhong, L., Su, X., Rong, R., Hu, S., Liu, W., Jia, B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2512 · Cited by 70 · see citing works
Plouhinec, J.-L., Medina-Ruiz, S., Borday, C., Bernard, E., Vert, J., Eisen, M. B., Harland, R. M., & Monsoro-Burq, A. H. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2004045 · Cited by 69 · see citing works
Tian, Y., & Guo, W. (2020) · Medical Science Monitor · doi:10.12659/msm.920957 · Cited by 68 · see citing works
Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
Redmer, T. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0854-5 · Cited by 67 · see citing works
Joseph, C., Arshad, M., Kurozomi, S., Althobiti, M. M., Miligy, I. M., Al-izzi, S., Toss, M. S., Goh, F. Q., Johnston, S. J., Martin, S. G., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05085-9 · Cited by 66 · see citing works
Varum, S., Baggiolini, A., Zurkirchen, L., Atak, Z. K., Cantù, C., Marzorati, E., Bossart, R., Wouters, J., Häusel, J., Tuncer, E., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.011 · Cited by 65 · see citing works
Self-citationNeuhold, J. C., Friesenhahn, J., Gerdes, N., & Krengel, S. (2014) · Pediatric Dermatology · doi:10.1111/pde.12400 · Cited by 65 · see citing works
Diener, J., & Sommer, L. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0351 · Cited by 64 · see citing works
Self-citationRhoJ Regulates Melanoma Chemoresistance by Suppressing Pathways That Sense DNA Damage
Ho, H., Aruri, J., Kapadia, R., Mehr, H., White, M. A., & Ganesan, A. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0775 · Cited by 64 · see citing works
Transcription factor Sox10 regulates oligodendroglial Sox9 levels via microRNAs
Reiprich, S., Cantone, M., Weider, M., Baroti, T., Wittstatt, J., Schmitt, C., Küspert, M., Vera, J., & Wegner, M. (2017) · Glia · doi:10.1002/glia.23146 · Cited by 64 · see citing works
Self-citationGabellini, C., Gómez‐Abenza, E., Ibáñez‐Molero, S., Tupone, M. G., Pérez‐Oliva, A. B., de Oliveira, S., Bufalo, D. D., & Mulero, V. (2017) · International Journal of Cancer · doi:10.1002/ijc.31075 · Cited by 63 · see citing works
Powell, D. R., Blasky, A. J., Britt, S. G., & Artinger, K. B. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1224 · Cited by 62 · see citing works
Beard, R. E., Abate‐Daga, D., Rosati, S. F., Zheng, Z., Wunderlich, J. R., Rosenberg, S. A., & Morgan, R. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1253 · Cited by 61 · see citing works
Eliades, P. J., Abraham, B. J., Ji, Z., Miller, D. M., Christensen, C. L., Kwiatkowski, N. P., Kumar, R., Njauw, C.-N. J., Taylor, M., Miao, B., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.09.056 · Cited by 58 · see citing works
Links between S chwann cells and melanocytes in development and disease
Raamsdonk, C. D. V., & Deo, M. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12134 · Cited by 56 · see citing works
Yin, T., Wang, G., Wang, L., Mudgal, P., Wang, E., Pan, C. C., Alexander, P. B., Wu, H., Cao, C., Liang, Y., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01723-7 · Cited by 55 · see citing works
Lobikin, M., Lobo, D., Blackiston, D. J., Martyniuk, C. J., Tkachenko, E., & Levin, M. G. (2015) · Science Signaling · doi:10.1126/scisignal.aac6609 · Cited by 55 · see citing works
Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction
Klaus, M., Prokoph, N., Girbig, M., Wang, X., Huang, Y., Srivastava, Y., Hou, L., Narasimhan, K., Kolatkar, P. R., François, M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw130 · Cited by 55 · see citing works
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma
Eskiocak, B., McMillan, E. A., Mendiratta, S., Kollipara, R. K., Zhang, H., Humphries, C. G., Wang, C., García‐Rodríguez, J., Ding, M. L., Zaman, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0955 · Cited by 55 · see citing works
Testing the cancer stem cell hypothesis in melanoma: The clinics will tell
Shakhova, O., & Sommer, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.009 · Cited by 54 · see citing works
Self-citationNeural crest stem cells in melanoma development
Shakhova, O. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000046 · Cited by 54 · see citing works
Self-citationCre‐driver lines used for genetic fate mapping of neural crest cells in the mouse: An overview
Debbache, J., Parfejevs, V., & Sommer, L. (2018) · genesis · doi:10.1002/dvg.23105 · Cited by 54 · see citing works
Self-citationPutative role of HIF transcriptional activity in melanocytes and melanoma biology
Zbytek, B., Peacock, D. L., Seagroves, T. N., & Slominski, A. T. (2013) · Dermato-Endocrinology · doi:10.4161/derm.22678 · Cited by 52 · see citing works
Panaccione, A., Chang, M. T., Carbone, B. E., Guo, Y. P., Moskaluk, C. A., Virk, R. K., Chiriboga, L. A., Prasad, M. L., Judson, B. L., Mehra, S., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2208 · Cited by 52 · see citing works
SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET
Du, F., Li, X., Feng, W., Qiao, C., Chen, J., Jiang, M., Qiu, Z., Qian, M., Tian, D., Nie, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1233-4 · Cited by 51 · see citing works
Fufa, T., Harris, M. L., Watkins‐Chow, D. E., Levy, D. J., Gorkin, D. U., Gildea, D. E., Song, L., Safi, A., Crawford, G. E., Sviderskaya, E. V., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv267 · Cited by 51 · see citing works
Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
Goldinger, S. M., Murer, C., Stieger, P., & Dummer, R. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.011 · Cited by 47 · see citing works
Self-citationMelanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Testa, U., Castelli, G., & Pelosi, E. (2017) · Medical Sciences · doi:10.3390/medsci5040028 · Cited by 48 · see citing works
SOX9 is a dose-dependent metastatic fate determinant in melanoma
Yang, X., Liang, R., Liu, C., Liu, J. A., Cheung, M. P. L., Liu, X., Man, O. Y., Guan, X.-Y., Lung, H. L., & Cheung, M. C. H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0998-6 · Cited by 45 · see citing works
SOX10-MITF pathway activity in melanoma cells
Tudrej, K. B., Czepielewska, E., & Kozłowska−Wojciechowska, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60655 · Cited by 44 · see citing works
The gene regulatory basis of genetic compensation during neural crest induction
Dooley, C. M., Wali, N., Sealy, I. M., White, R. J., Stemple, D. L., Collins, J. E., & Busch-Nentwich, E. M. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008213 · Cited by 40 · see citing works
Identification and functional analysis of SOX10 phosphorylation sites in melanoma
Cronin, J. C., Loftus, S. K., Baxter, L. L., Swatkoski, S., Guček, M., & Pavan, W. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190834 · Cited by 39 · see citing works
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion
Graf, S. A., Heppt, M. V., Wessely, A., Krebs, S., Kammerbauer, C., Hornig, E., Strieder, A., Blum, H., Bosserhoff, A., & Berking, C. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12760 · Cited by 39 · see citing works
LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction
Ma, Y., Wang, L., He, F., Yang, J., Ding, Y., Ge, S., Fan, X., Zhou, Y., Xu, X., & Jia, R. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.022 · Cited by 39 · see citing works
Melanocyte lineage dynamics in development, growth and disease
Brombin, A., & Patton, E. E. (2024) · Development · doi:10.1242/dev.201266 · Cited by 36 · see citing works
Wu, H., Larribère, L., Sun, Q., Novak, D., Sachindra, S., Granados, K., Umansky, V., & Utikal, J. S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31799 · Cited by 36 · see citing works
Transcriptional regulators and alterations that drive melanoma initiation and progression
Gupta, R., Janoštiak, R., & Wajapeyee, N. (2020) · Oncogene · doi:10.1038/s41388-020-01490-x · Cited by 36 · see citing works
Reactivation of embryonic genetic programs in tissue regeneration and disease
Fazilaty, H., & Basler, K. (2023) · Nature Genetics · doi:10.1038/s41588-023-01526-4 · Cited by 35 · see citing works
SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
Rosenbaum, S. R., Tiago, M., Caksa, S., Capparelli, C., Purwin, T. J., Kumar, G., Glasheen, M. Q., Pomante, D., Kotas, D., Chervoneva, I., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110085 · Cited by 35 · see citing works
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma
Olvedy, M., Tisserand, J. C., Luciani, F., Boeckx, B., Wouters, J., Lopez, S., Rambow, F., Aibar, S., Thienpont, B., Barra, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91291 · Cited by 34 · see citing works
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25326-8 · Cited by 34 · see citing works
Self-citationTopical therapy for regression and melanoma prevention of congenital giant nevi
Choi, Y. S., Erlich, T. H., von Franque, M., Rachmin, I., Flesher, J. L., Schiferle, E. B., Zhang, Y., da Silva, M. P., Jiang, A. Y., Dobry, A. S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.025 · Cited by 35 · see citing works
Sox2 is dispensable for primary melanoma and metastasis formation
Schaefer, S. M., Segalada, C., Cheng, P. F., Bonalli, M., Parfejevs, V., Levesque, M. P., Dummer, R., Nicolis, S. K., & Sommer, L. (2017) · Oncogene · doi:10.1038/onc.2017.55 · Cited by 33 · see citing works
Self-citationSFPQ promotes an oncogenic transcriptomic state in melanoma
Bi, O., Anene, C. A., Nsengimana, J., Shelton, M., Roberts, W., Newton‐Bishop, J., & Boyne, J. R. (2021) · Oncogene · doi:10.1038/s41388-021-01912-4 · Cited by 32 · see citing works
Tfap2b specifies an embryonic melanocyte stem cell that retains adult multifate potential
Brombin, A., Simpson, D. J., Trávníčková, J., Brunsdon, H., Zeng, Z., Lu, Y., Young, A. I. J., Chandra, T., & Patton, E. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110234 · Cited by 32 · see citing works
Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
Saei, A., & Eichhorn, P. J. A. (2019) · Cancers · doi:10.3390/cancers11081176 · Cited by 31 · see citing works
Clinical Significance of SOX10 Expression in Human Pathology
Bahmad, H. F., Thiravialingam, A., Sriganeshan, K., Gonzalez, J., Alvarez, V., Ocejo, S., Abreu, A. D. C., Avellan, R., Arzola, A., Hachem, S., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120633 · Cited by 31 · see citing works
Uka, R., Britschgi, C., Krättli, A., Matter, C., Mihic‐Probst, D., Okoniewski, M. J., Gualandi, M., Stupp, R., Cinelli, P., Dummer, R., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1267-7 · Cited by 32 · see citing works
Self-citationHow, and from which cell sources, do nevi really develop?
Grichnik, J. M., Ross, A. L., Schneider, S. L., Sanchez, M. I., Eller, M. S., & Hatzistergos, K. E. (2014) · Experimental Dermatology · doi:10.1111/exd.12363 · Cited by 30 · see citing works
TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression
Bonvin, E., Radaelli, E., Bizet, M., Luciani, F., Calonne, E., Putmans, P., Nittner, D., Singh, N. K., Santagostino, S. F., Petit, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1214 · Cited by 30 · see citing works
Larribère, L., & Utikal, J. S. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00111 · Cited by 28 · see citing works
Effect of melanoma stem cells on melanoma metastasis (Review)
Yin, Q., Shi, X., Lan, S., Jin, H., & Wu, D. (2021) · Oncology Letters · doi:10.3892/ol.2021.12827 · Cited by 30 · see citing works
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family
Zage, P. E., Whittle, S. B., & Shohet, J. M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25656 · Cited by 30 · see citing works
Extended Multipotency of Neural Crest Cells and Neural Crest-Derived Cells
Motohashi, T., & Kunisada, T. (2015) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.003 · Cited by 29 · see citing works
Geometric regulation of histone state directs melanoma reprogramming
Lee, J., Molley, T. G., Seward, C. H., Abdeen, A. A., Zhang, H., Wang, X., Gandhi, H., Yang, J.-L., Gaus, K., & Kilian, K. A. (2020) · Communications Biology · doi:10.1038/s42003-020-1067-1 · Cited by 28 · see citing works
Decoding the Role of CD271 in Melanoma
Vidal, A., & Redmer, T. (2020) · Cancers · doi:10.3390/cancers12092460 · Cited by 36 · see citing works
- Authors
- Shakhova, O., Zingg, D., Schaefer, S. M., Hari, L., Civenni, G., Blunschi, J., Claudinot, S., Okoniewski, M., Beermann, F., Mihic-Probst, D., Moch, H., Wegner, M., Dummer, R., Barrandon, Y., Cinelli, P., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- École Polytechnique Fédérale de Lausanne (CH)
- Functional Genomics Center Zurich (CH)
- University Hospital Zurich (CH)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Shakhova, Olga
- Sommer, Lukas
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2012-07-08
- Volume
- 14
- Issue
- 8
- Pages
- 882-890
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1985577088
- Cited by
- 274
- References
- 33
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 10 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 27 · 2019: 18 · 2018: 18 · 2017: 28 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 5
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NRP 63)
- Universität Zürich
- Functional Genomics Center Zurich
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- SOX10, melanoma, neural crest stem cells, melanocyte development, NRAS Q61K, cell proliferation, cell survival, mouse model
- MeSH terms
- Animals, Cell Line, Child, Disease Models, Animal, Female, Humans, Immunohistochemistry, Infant, Male, Melanoma, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Nevus, Biomarkers, Tumor, Blotting, Western, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Microarray Analysis, Mice, SOXE Transcription Factors, Haploinsufficiency, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review